Skip to content
Catalyst

PapersPMID:30108163

Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome.

Gut2019The record ↗

  1. Finding, moderate evidencelowersStool frequency

What moved

1 findingHow to read these marks →
  • “Glutamine also (i) reduced daily bowel movement frequency (p<0.0001), (ii) improved stool form on the Bristol Stool Scale (p<0.0001), and (iii) normalized intestinal hyperpermeability (where hyperpermeability is defined as an elevated urinary lactulose/mannitol ratio > 0.07) (p<0.0001).”
    Study
    RCT
    Participants
    106
    Duration
    8 weeks
    Dose studied
    glutamine powder 5 g orally three times daily for 8 weeks
    Population
    adults with post-infectious diarrhoea-predominant IBS (IBS-D) and intestinal hyperpermeability

Study record

Design
randomised controlled trial
Species
human
Population
adults with post-infectious diarrhoea-predominant IBS (IBS-D) and intestinal hyperpermeability
Participants
115
Comparator
placebo
Duration
56 days
Endpoints measured
5